Literature DB >> 2530883

Effects of amlodipine on renal hemodynamics.

R D Loutzenhiser1, M Epstein, F Fischetti, C Horton.   

Abstract

Recently, attention has focused on the effects of calcium antagonists on renal function. When administered in vitro to the isolated perfused kidney, calcium antagonists exhibit consistent actions permitting characterization of their renal effects. Calcium antagonists do not affect the vasodilated isolated perfused kidney, but they do dramatically alter the response of the kidney to vasoconstrictor agents. This study examined the effects of the novel dihydropyridine amlodipine on the hemodynamic response of the isolated perfused kidney to angiotensin II. Amlodipine completely reversed the angiotensin II-induced decrement in glomerular filtration rate of this model (0.72 +/- 0.15, 0.26 +/- 0.10 and 0.73 +/- 0.12 ml/min/g for control, angiotensin II and angiotensin II plus 0.1 microM amlodipine respectively). In contrast, amlodipine only partially restored renal perfusate flow (35.8 +/- 2.7, 14.7 +/- 1.9 and 23.7 +/- 2.5 ml/min/g for control, angiotensin II and angiotensin II plus amlodipine), thereby increasing filtration fraction. These findings are consistent with previous observations from this laboratory indicating that dihydropyridines predominantly vasodilate preglomerular renal resistance vessels and through this mechanism exert a preferential augmentation of glomerular filtration rate.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530883     DOI: 10.1016/0002-9149(89)90969-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.

Authors:  D Murdoch; R C Heel
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

2.  Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.

Authors:  Mahboob Rahman; Charles E Ford; Jeffrey A Cutler; Barry R Davis; Linda B Piller; Paul K Whelton; Jackson T Wright; Joshua I Barzilay; Clinton D Brown; Pedro J Colon; Lawrence J Fine; Richard H Grimm; Alok K Gupta; Charles Baimbridge; L Julian Haywood; Mario A Henriquez; Ekambaram Ilamaythi; Suzanne Oparil; Richard Preston
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-05       Impact factor: 8.237

3.  Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients. A randomized controlled study versus placebo.

Authors:  G Licata; R Scaglione; A Ganguzza; G Parrinello; R Costa; G Merlino; S Corrao; P Amato
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Renal outcomes of diabetic patients treated with combination therapy of ACE inhibitors plus either thiazide diuretics or calcium channel blockers: comparative retrospective cohort study in Northwestern Ethiopia.

Authors:  Adeladlew Kassie Netere; Esmael Ali Muhammad; Mezgebu Silamsaw Asres; Masho Tigabie Teklie
Journal:  BMJ Open       Date:  2021-11-25       Impact factor: 3.006

Review 5.  Renal microcirculation and calcium channel subtypes.

Authors:  Koichiro Homma; Koichi Hayashi; Shintaro Yamaguchi; Seitaro Fujishima; Shingo Hori; Hiroshi Itoh
Journal:  Curr Hypertens Rev       Date:  2013-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.